xueyitingwang

Teladoc’s $18.5B merger with Livongo

–Authored by Xueyiting Wang, King’s College London Overview of the deal Acquirer: Teladoc Health Target: Livongo Estimated Value: $18.5B Announced Date: 8/5/2020 Closed Date: 10/30/2020 Transaction Advisor(s): Lazard served as exclusive financial advisor to Teladoc Health and Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor. Morgan Stanley served as exclusive financial advisor …

Teladoc’s $18.5B merger with Livongo Read More »

The Deal Between AMD and Xilinx

–By Xueyiting Wang, King’s College London Overview of the Deal Acquirer: Advanced Micro Devices, IncTarget: Xilinx, IncEstimated value: $35 billionAnnounced date: October 27th, 2020Closed date: By the end of the 2021Financial advisors to AMD: Credit Suisse and DBO Partners Financial advisors to Xilinx: Morgan Stanley BofA Securities AMD, the US semiconductor design company, announced on …

The Deal Between AMD and Xilinx Read More »